Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry is a research paper published in Journal for ImmunoTherapy of Cancer (2025). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Health Resources and Services Administration
Grant: HHSH250201700005C
Health Resources and Services Administration
Grant: HHSH250201700006C
Health Resources and Services Administration
Grant: HHSH250201700007C
Office of Naval Research
Grant: N00014-20-1-2832
Office of Naval Research
Grant: N00014-21-1-2954
National Heart, Lung, and Blood Institute
Grant: OT3HL147741
National Heart, Lung, and Blood Institute
Grant: U01HL128568
National Heart, Lung, and Blood Institute
Grant: U24CA076518
National Heart, Lung, and Blood Institute
Grant: U24HL138660
National Heart, Lung, and Blood Institute
Grant: U24HL157560
National Cancer Institute
Grant: U24CA233032
U.S. Government
Grant: P01CA111412
U.S. Government
Grant: R01AI128775
U.S. Government
Grant: R01AI150999
U.S. Government
Grant: R01AI158861
U.S. Government
Grant: R01CA100019
U.S. Government
Grant: R01CA152108
U.S. Government
Grant: R01CA218285
U.S. Government
Grant: R01CA231141
U.S. Government
Grant: R01CA231838
U.S. Government
Grant: R01CA262899
U.S. Government
Grant: R01HL131731
U.S. Government
Grant: R01HL155741
U.S. Government
Grant: SC1MC31881
U.S. Government
Grant: U01AI069197
U.S. Government
Grant: U01AI126612
U.S. Government
Grant: UG1HL06924
U.S. Government
Grant: UM1CA121947
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: U01 CA083038
National Institutes of Health
Grant: 5U01HL128568-02
Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC
National Institutes of Health
Grant: 1U24HL138660-01
Blood and Marrow Transplant Clinical Trials Network Data Coordinating Center
National Institutes of Health
Grant: 2U24CA076518-16
A Data Resource for Analyzing Blood and Marrow Transplants
National Institutes of Health
Grant: 3OT3HL147741-01S1
Cure Sickle Cell
National Institutes of Health
Grant: 5R01HL155741-03
Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes
National Institutes of Health
Grant: 1U01AI126612-01A1
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
National Institutes of Health
Grant: 5R01CA231838-09
Immunogenetics of Outcomes Disparities After Allogeneic HCT
National Institutes of Health
Grant: 3UM1CA121947-19S9
Consortium for Advancing Management and Prevention of Cancer in People with HIV
National Institutes of Health
Grant: 5R01CA262899-05
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation
National Institutes of Health
Grant: 1U24CA233032-01
Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR)
National Institutes of Health
Grant: 5R01AI150999-04
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
National Institutes of Health
Grant: 5P01CA111412-04
NK Cells, Their Receptors and Unrelated Donor Transplant
Jazz Pharmaceuticals
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5U01AI069197-15
Hematopoietic Stem Cell and Cord Blood Transplantation
National Institutes of Health
Grant: 5R01AI128775-11
Integrated Exchange and Storage of Current- and Future-Generation Immunogenomic Data
National Institutes of Health
Grant: 6R01CA218285-06
Immuno and Epigenetics of Hematopoietic Cell Transplantation
National Institutes of Health
Grant: 5R01CA231141-02
Genetics of Graft-versus-Host Disease
National Institutes of Health
Grant: 5U24HL157560-03
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
National Institutes of Health
Grant: 5R01HL131731-05
Identifying Predictors of Poor Health-Related Quality-of-life among Pediatric Hematopoietic Stem Cell Donors
National Institutes of Health
Grant: 1R01AI158861-01
The landscape of HLA mediated variation in health and immunity
National Institutes of Health
Grant: 5R01CA100019-10
Clinical Significance of MHC Haplotypes in HCT
National Institutes of Health
Grant: 5R01CA152108-04
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)
Allovir, Inc.
Anthem Foundation
Boston Children’s Hospital
CRISPR
GlaxoSmithKline
Iovance Biotherapeutics
Janssen/Johnson & Johnson
Miltenyi Biotec, Inc.
National Marrow Donor Program
Takeda Oncology Co.
AbbVie
Actinium Pharmaceuticals
Fate Therapeutics
Janssen Research & Development, LLC
Kadmon, a Sanofi Company
Medical College of Wisconsin
Novartis Pharmaceuticals Corporation
OptumHealth
Priothera
Xenikos BV
AstraZeneca
CSL Behring
Gamida-Cell, Ltd.
Gilead Sciences
Kiadis Pharma
Allogene Therapeutics
Amgen, Inc.
Astellas Pharma US
Be The Match Foundation
Bristol Myers Squibb Co.
Talaris Therapeutics
Terumo Blood and Cell Technologies
bluebird bio
ADC Therapeutics
Jasper Therapeutics
Jazz Pharmaceuticals
Karius
Mallinckrodt Pharmaceuticals
Omeros Corporation
Orca Biosystems, Inc.
Sanofi
TG Therapeutics
Adienne SA
BeiGene
Dana-Farber Cancer Institute
Legend Biotech
Medexus Pharma
Merck & Co.
MorphoSys
StemCyte
Adaptive Biotechnologies Corporation
CytoSen Therapeutics, Inc.
Incyte Corporation
Kyowa Kirin Pharmaceutical Development
Magenta Therapeutics
Millennium, the Takeda Pharmaceuticals
Sanofi-Aventis
Sobi, Inc.
St. Baldrick’s Foundation
Atara Biotherapeutics
CareDx
Eurofins Viracor, DBA Eurofins Transplant Diagnostics
HistoGenetics
Kite, a Gilead Company
Medac GmbH
Ossium Health, Inc.
PBMTF
Pfizer, Inc.
Pharmacyclics, LLC
Stanford University
Vertex Pharmaceuticals
FWCI
6.87
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals